Tesla To $175? Here Are 10 Other Price Target Changes For Friday

Loading...
Loading...
  • Oppenheimer cut CarMax, Inc. KMX price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market trading.
  • JP Morgan cut Paychex, Inc. PAYX price target from $121 to $119. JP Morgan analyst Tien-Tsin Huang maintained an Underweight rating on the stock. Paychex rose 2.1% to $114.48 in pre-market trading.
  • Stephens & Co. slashed the price target on Mission Produce, Inc. AVO from $20 to $15. Stephens & Co. analyst Ben Bienvenu maintained an Overweight rating on the stock. Mission Produce shares fell 14.1% to $12.55 in pre-market trading.
  • B. Riley Securities raised Cleveland-Cliffs Inc. CLF price target from $26 to $27. B. Riley Securities analyst Lucas Pipes maintained a Buy rating on the stock. Cleveland-Cliffs shares rose 0.6% to $17.02 in pre-market trading.
  • Loop Capital cut Paramount Global PARA price target from $30 to $14. Loop Capital analyst Alan Gould downgraded the stock from Hold to Sell. Paramount Global shares fell 1.2% to $16.74 in pre-market trading.
  • Needham cut Cytokinetics, Incorporated CYTK price target from $60 to $58. Needham analyst Serge Belanger maintained a Buy rating on the stock. Cytokinetics shares fell 3% to $46.01 in pre-market trading.
  • Roth Capital raised Ligand Pharmaceuticals Incorporated LGND price target from $85 to $90. Roth Capital analyst Scott Henry maintained a Buy rating on the stock. Ligand Pharmaceuticals shares rose 2.7% to close at $67.03 on Thursday.
  • Wedbush cut Tesla, Inc. TSLA price target from $250 to $175. Wedbush analyst Daniel Ives maintained an Outperform rating on the stock. Tesla shares rose 0.9% to $126.41 in pre-market trading.
  • Raymond James raised ProQR Therapeutics N.V. PRQR price target from $2 to $5. Raymond James analyst Steven Seedhouse maintained an Outperform rating on the stock. ProQR Therapeutics shares fell 4.4% to $2.58 in pre-market trading.
  • B of A Securities cut Rocket Pharmaceuticals, Inc. RCKT price target from $38 to $35. B of A Securities analyst Greg Harrison maintained a Buy rating on the stock. Rocket Pharmaceuticals shares fell 0.9% to $19.02 in pre-market trading.
  • Needham cut VIZIO Holding Corp. VZIO price target from $16 to $11. Needham analyst Laura Martin maintained a Buy rating on the stock. VIZIO Holding shares rose 4.2% to $8.28 in pre-market trading.

Check This Out: Most Affordable Stocks In The Consumer Discretionary Sector: Tesla, Ford And More

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsPenny StocksPrice TargetSmall CapMarketsAnalyst RatingsTrading IdeasBiotechnologyHealth CarePrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...